Colinz Laboratories Limited (COLINZ.BO)
INR 50.48
(4.99%)
INR 50.48
(4.99%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 24.1 Million INR | 15.25% |
| 2022 | 20.91 Million INR | -6.79% |
| 2021 | 22.44 Million INR | -20.18% |
| 2020 | 28.11 Million INR | 42.48% |
| 2019 | 19.73 Million INR | -15.4% |
| 2018 | 23.32 Million INR | -17.85% |
| 2017 | 28.39 Million INR | -9.94% |
| 2016 | 31.52 Million INR | -9.69% |
| 2015 | 34.9 Million INR | -22.31% |
| 2014 | 44.93 Million INR | 22.54% |
| 2013 | 36.67 Million INR | 1.95% |
| 2012 | 35.97 Million INR | -10.94% |
| 2011 | 40.38 Million INR | -3.13% |
| 2010 | 41.69 Million INR | 1.16% |
| 2009 | 41.21 Million INR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 30.13 Million INR | 133.67% |
| 2024 Q1 | -89.48 Million INR | -471.25% |
| 2023 Q2 | 24.76 Million INR | 0.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 FY | 24.1 Million INR | 15.25% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q4 | 24.1 Million INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q2 | 27.19 Million INR | 0.0% |
| 2022 FY | 20.91 Million INR | -6.79% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q4 | 20.91 Million INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q1 | - INR | -100.0% |
| 2021 Q4 | 22.44 Million INR | 0.0% |
| 2021 Q2 | 29.23 Million INR | 0.0% |
| 2021 FY | 22.44 Million INR | -20.18% |
| 2020 Q1 | - INR | -100.0% |
| 2020 Q3 | - INR | -100.0% |
| 2020 Q2 | 24.9 Million INR | 0.0% |
| 2020 Q4 | 28.11 Million INR | 0.0% |
| 2020 FY | 28.11 Million INR | 42.48% |
| 2019 Q1 | - INR | -100.0% |
| 2019 Q3 | - INR | -100.0% |
| 2019 Q4 | 19.73 Million INR | 0.0% |
| 2019 Q2 | 20.09 Million INR | 0.0% |
| 2019 FY | 19.73 Million INR | -15.4% |
| 2018 FY | 23.32 Million INR | -17.85% |
| 2018 Q2 | 29.32 Million INR | 0.0% |
| 2018 Q1 | - INR | -100.0% |
| 2018 Q4 | 23.32 Million INR | 0.0% |
| 2018 Q3 | - INR | -100.0% |
| 2017 Q1 | - INR | -100.0% |
| 2017 Q2 | 27.77 Million INR | 0.0% |
| 2017 FY | 28.39 Million INR | -9.94% |
| 2017 Q4 | 28.39 Million INR | 0.0% |
| 2016 Q3 | - INR | -100.0% |
| 2016 FY | 31.52 Million INR | -9.69% |
| 2016 Q4 | 31.52 Million INR | 0.0% |
| 2016 Q2 | 33.09 Million INR | 0.0% |
| 2016 Q1 | - INR | -100.0% |
| 2015 FY | 34.9 Million INR | -22.31% |
| 2015 Q4 | 34.84 Million INR | 0.0% |
| 2015 Q3 | - INR | -100.0% |
| 2015 Q2 | 35.98 Million INR | 0.0% |
| 2015 Q1 | - INR | -100.0% |
| 2014 Q1 | - INR | -100.0% |
| 2014 FY | 44.93 Million INR | 22.54% |
| 2014 Q4 | 44.93 Million INR | 0.0% |
| 2014 Q3 | - INR | -100.0% |
| 2014 Q2 | 39.01 Million INR | 0.0% |
| 2013 Q4 | 36.67 Million INR | 0.0% |
| 2013 FY | 36.67 Million INR | 1.95% |
| 2013 Q3 | - INR | -100.0% |
| 2013 Q1 | - INR | -100.0% |
| 2013 Q2 | 37.87 Million INR | 0.0% |
| 2012 FY | 35.97 Million INR | -10.94% |
| 2012 Q4 | 35.97 Million INR | 0.0% |
| 2011 Q4 | 40.38 Million INR | 0.0% |
| 2011 FY | 40.38 Million INR | -3.13% |
| 2010 FY | 41.69 Million INR | 1.16% |
| 2009 FY | 41.21 Million INR | 0.0% |
| 2009 Q4 | 41.21 Million INR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| DECIPHER LABS LIMITED | 117.72 Million INR | 79.524% |
| Gujarat Themis Biosyn Limited | 197.37 Million INR | 87.787% |
| Ishita Drugs and Industries Limited | 8.87 Million INR | -171.697% |
| MedPlus Health Services Limited | 14.27 Billion INR | 99.831% |
| ANG Lifesciences India Limited | 1.66 Billion INR | 98.549% |
| Add-Shop E-Retail Limited | 159.2 Million INR | 84.859% |
| Bacil Pharma Limited | 1.12 Million INR | -2035.075% |
| BDH Industries Limited | 312.53 Million INR | 92.287% |
| Beryl Drugs Limited | 85.63 Million INR | 71.852% |
| Cian Healthcare Limited | 1.03 Billion INR | 97.67% |
| Chemo Pharma Laboratories Limited | 2.12 Million INR | -1032.754% |
| Concord Drugs Limited | 249.88 Million INR | 90.354% |
| Deccan Health Care Limited | 111.33 Million INR | 78.349% |
| Gujarat Terce Laboratories Limited | 161.67 Million INR | 85.09% |
| Hindustan Bio Sciences Limited | 25.7 Million INR | 6.21% |
| Jenburkt Pharmaceuticals Limited | 201.59 Million INR | 88.043% |
| KIMIA BIOSCIENCES LIMITED | 996.35 Million INR | 97.581% |
| Kwality Pharmaceuticals Limited | 1.71 Billion INR | 98.595% |
| Makers Laboratories Limited | 569.18 Million INR | 95.765% |
| Medi-Caps Limited | 63.01 Million INR | 61.748% |
| Panchsheel Organics Limited | 340.2 Million INR | 92.915% |
| Parmax Pharma Limited | 117.56 Million INR | 79.497% |
| Parnax Lab Limited | 1.17 Billion INR | 97.941% |
| Patidar Buildcon Limited | 25.57 Million INR | 5.737% |
| Phaarmasia Limited | 211.49 Million INR | 88.603% |
| Vikram Thermo (India) Limited | 291.47 Million INR | 91.73% |
| Sanjivani Paranteral Limited. | 155.06 Million INR | 84.455% |
| SHAMROCK INDUSTRIAL CO.LTD. | 299 Thousand INR | -7961.873% |
| Smruthi Organics Limited | 485.72 Million INR | 95.037% |
| Source Natural Foods and Herbal Supplements Limited | 41.97 Million INR | 42.569% |
| SUDARSHAN PHARMA INDUSTRIES LI | 1.71 Billion INR | 98.594% |
| Trident Lifeline Limited | 331.26 Million INR | 92.723% |
| Transchem Limited | 6.72 Million INR | -258.705% |
| Trinity League India Limited | 876 Thousand INR | -2651.712% |
| Tyche Industries Limited | 101.64 Million INR | 76.284% |
| Vista Pharmaceuticals Limited | 175.16 Million INR | 86.239% |
| Vivanza Biosciences Limited | 148.63 Million INR | 83.782% |
| PRAVEG LIMITED | 767.53 Million INR | 96.859% |
| Sastasundar Ventures Limited | 1.5 Billion INR | 98.394% |
| Sunil Healthcare Limited | 902.83 Million INR | 97.33% |
| Syschem (India) Limited | 1.07 Billion INR | 97.749% |
| Zenith Healthcare Limited | 24.03 Million INR | -0.291% |
| Zenlabs Ethica Limited | 301.35 Million INR | 92.001% |
| Mercury Laboratories Limited | 171.18 Million INR | 85.919% |
| SHELTER PHARMA LIMITED | 20.99 Million INR | -14.84% |
| Vasundhara Rasayans Limited | 53.64 Million INR | 55.067% |
| Bharat Immunologicals & Biologicals Corporation Limited | 1 Billion INR | 97.6% |
| Roopa Industries Limited | 493.08 Million INR | 95.111% |
| PANJON LTD. | 25.38 Million INR | 5.035% |
| Pharmaids Pharmaceuticals Limited | 208.44 Million INR | 88.436% |
| TIAAN CONSUMER LIMITED | 14.97 Million INR | -60.925% |
| Anuh Pharma Limited | 1.54 Billion INR | 98.439% |
| Crestchem Limited | 23.94 Million INR | -0.66% |
| Emmessar Biotech & Nutrition Limited | 13.4 Million INR | -79.821% |
| Sandu Pharmaceuticals Limited | 118.22 Million INR | 79.611% |
| Fredun Pharmaceuticals Limited | 1.86 Billion INR | 98.705% |
| Trimurthi Limited | 101.36 Thousand INR | -23681.571% |
| Shukra Pharmaceuticals Limited | 201.97 Million INR | 88.065% |
| Norris Medicines Limited | 278.17 Million INR | 91.335% |
| Veerhealth Care Limited | 62.78 Million INR | 61.604% |
| Lactose (India) Limited | 536.39 Million INR | 95.506% |
| OXYGENTA PHARMACEUTICAL LIMITE | 833.14 Million INR | 97.107% |
| Ambalal Sarabhai Enterprises Limited | 1.13 Billion INR | 97.869% |
| Gennex Laboratories Limited | 535.21 Million INR | 95.496% |
| Denis Chem Lab Limited | 289.82 Million INR | 91.683% |
| Godavari Drugs Limited | 957.86 Million INR | 97.483% |
| Zenotech Laboratories Limited | 156.64 Million INR | 84.612% |
| Shree Ganesh Remedies Limited | 488.36 Million INR | 95.064% |
| Bharat Parenterals Limited | 2.65 Billion INR | 99.093% |
| Coral Laboratories Limited | 281.83 Million INR | 91.447% |
| Evoq Remedies Limited | 116.23 Million INR | 79.261% |
| Kerala Ayurveda Limited | 1.05 Billion INR | 97.721% |
| KOBO BIOTECH LIMITED | 2.04 Billion INR | 98.82% |
| Natural Capsules Limited | 1.47 Billion INR | 98.368% |
| Auro Laboratories Limited | 433.09 Million INR | 94.434% |